The FCF Life Sciences IPO Report examines recent IPO trends in the Life Sciences sector, with a strong focus on the comparison of European and US characteristics.
LIFE SCIENCES RESEARCH SERIES
We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our FCF Life Sciences Research Series focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:
Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Biotech Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
Life Sciences Venture Capital ReportRecent Venture capital trends in the European Life Sciences sector
Biotech Licensing Monitor – China-Upcoming-Recent licensing trends of European Biotech companies in China
Life Sciences IPO ReportRecent IPO trends in the Life Sciences sector
Biotech Public Equity MonitorRecent valuations of listed European Life Sciences companies
MedTech Public Equity Monitor-Upcoming-Recent valuations of listed MedTech companies
NEWS & PRESS
FCF Life Sciences Venture Capital Report – 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Report – 2020”. The Venture Capital Report, part of FCF Life Sciences Research Series, is the most detailed and
FCF Life Sciences Venture Capital Monitor – Europe 01/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 01/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life
FCF Biotech Venture Capital Monitor – USA 01/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 01/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences Venture Capital Monitor – Europe 12/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2020”. The Monitor is a monthly published overview of venture capital trends in the European Life
Dr. Joachim Greuel is the latest expert to join the Life Sciences Advisory Board at FCF Fox Corporate Finance GmbH
Complementing the leading industry experts already advising the Munich-based corporate financing specialist, Dr. Joachim Greuel joins FCF’s Life Sciences Advisory Board. Munich, January 18, 2021 FCF Fox Corporate Finance GmbH (“FCF”) welcomes yet another renowned
